What are the current pediatric dosing guidelines for piperacillin‑tazobactam (Zosyn)?

Piperacillin-Tazobactam Pediatric Dosing Guidelines

For children 2 months of age and older, administer piperacillin-tazobactam at 100 mg/kg (based on the piperacillin component) every 8 hours for infants older than 9 months, and 80 mg/kg every 8 hours for infants 2-9 months of age, with a maximum single dose not exceeding the adult dose. 1

FDA-Approved Standard Dosing by Age and Indication

Infants 2-9 Months

• 90 mg/kg (80 mg piperacillin/10 mg tazobactam) every 8 hours for appendicitis/peritonitis 1
• 90 mg/kg (80 mg piperacillin/10 mg tazobactam) every 6 hours for nosocomial pneumonia 1
• Administer as a 30-minute intravenous infusion 1

Children Older Than 9 Months (up to 40 kg)

• 112.5 mg/kg (100 mg piperacillin/12.5 mg tazobactam) every 8 hours for appendicitis/peritonitis 1
• 112.5 mg/kg (100 mg piperacillin/12.5 mg tazobactam) every 6 hours for nosocomial pneumonia 1
• Administer as a 30-minute intravenous infusion 1

Maximum Dose Considerations

• Do not exceed adult dosing equivalents on a per-kilogram basis when treating children 2
• The maximum daily dose for piperacillin-tazobactam is 18 g daily (16 g piperacillin/2 g tazobactam) 1

Alternative Dosing for Gram-Negative Enteric Bacilli (Including Endocarditis)

For severe infections caused by gram-negative enteric bacilli, the American Heart Association recommends:

• 240 mg/kg/day (based on piperacillin component) divided every 8 hours, up to 18 g daily 2
• This higher dosing is specifically recommended when used in combination with an aminoglycoside for endocarditis or other severe gram-negative infections 2

Extended-Infusion Dosing Strategies (Evidence-Based Optimization)

Recent pharmacokinetic studies support extended-infusion strategies for improved bacterial killing:

For Critically Ill Children (Ages 1-6 Years)

• 100 mg/kg every 6 hours administered as a 3-hour prolonged infusion achieves optimal target attainment at MIC ≤16 mg/L 3
• This regimen provides ≥50% free time above MIC (fT>MIC) for Pseudomonas aeruginosa at the CLSI breakpoint 3

For Children Ages 6 Months to 6 Years

• 130 mg/kg every 8 hours infused over 4 hours optimally targets bacteria with MICs up to 16 mg/L 4
• This extended infusion maintains free piperacillin concentrations above the MIC for ≥50% of the dosing interval 4

For Infants Ages 2-6 Months

• 75 mg/kg every 4 hours infused over 0.5 hours provides optimal coverage against bacteria with MICs up to 16 mg/L 4

Feasibility in Clinical Practice

• Extended-infusion piperacillin-tazobactam (administered over 4 hours) was successfully implemented in 92% of pediatric patients in a large observational study 5
• The primary barrier to extended infusion was coadministration of vancomycin due to compatibility concerns 5

Renal Impairment Dosing

• Reduce dosage in pediatric patients with creatinine clearance ≤40 mL/min based on the degree of renal impairment 1
• Creatinine clearance is a significant covariate affecting piperacillin clearance and should guide dose adjustments 6
• Monitor renal function during treatment, as piperacillin-tazobactam is an independent risk factor for renal failure in critically ill patients 1

Concomitant Furosemide Administration

• Furosemide coadministration significantly affects piperacillin clearance and should be considered when optimizing dosing 4
• Children receiving concomitant furosemide may require dose adjustments based on therapeutic drug monitoring when available 4

Administration Guidelines

• Administer by intravenous infusion over 30 minutes for standard dosing 1
• Extended infusions (3-4 hours) are preferred for critically ill children or when treating organisms with higher MICs 4, 3
• Piperacillin-tazobactam and aminoglycosides must be reconstituted, diluted, and administered separately; co-administration via Y-site is permissible only under specific compatibility conditions 1

Critical Pitfalls to Avoid

• Do not underdose infants 2-9 months of age: This population requires 80 mg/kg (not 100 mg/kg) due to immature renal function 1, 7
• Do not use standard 30-minute infusions for critically ill children with severe Pseudomonas infections: Extended infusions (3-4 hours) significantly improve target attainment 3
• Do not exceed adult maximum doses on a weight-based calculation, as this increases toxicity risk without additional benefit 2, 1
• Do not mix piperacillin-tazobactam with aminoglycosides in the same infusion: Physical incompatibility will inactivate both drugs 1
• Do not continue therapy without monitoring renal function in critically ill patients: Piperacillin-tazobactam carries an independent risk of acute kidney injury in this population 1

Duration of Therapy

• Typical treatment duration is 7-14 days depending on infection site, severity, and clinical response 8
• For endocarditis, treat for 4-6 weeks with combination aminoglycoside therapy 2